BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/2/2024 9:08:46 AM | Browse: 64 | Download: 119
 |
Received |
|
2023-08-27 07:52 |
|
Peer-Review Started |
|
2023-08-27 07:54 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-11-14 08:05 |
|
Revised |
|
2023-11-24 14:57 |
|
Second Decision |
|
2023-12-18 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-12-18 07:22 |
|
Articles in Press |
|
2023-12-18 07:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-12-11 10:34 |
|
Typeset the Manuscript |
|
2023-12-26 03:08 |
|
Publish the Manuscript Online |
|
2024-01-02 09:08 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Gut-targeted therapies for type 2 diabetes mellitus: A review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tian-Cheng Xu, Yun Liu, Zhi Yu and Bin Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
82074532, 82305376,81873238 |
| the Open Projects of the Discipline of Chinese Medicine of Nanjing University of Chinese Medicine supported by the Subject of Academic Priority Discipline of Jiangsu Higher Education Institutions |
ZYX03KF012 |
| the Postgraduate Research & Practice Innovation Program of Jiangsu Province |
KYCX22_1963 |
|
| Corresponding Author |
Bin Xu, MD, PhD, Director, Professor, Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, No. 138 Xianlin Road, Nanjing 210023, Jiangsu Province, China. xubin@njucm.edu.cn |
| Key Words |
Type 2 diabetes mellitus; Gastroenterology; Bacteria; Implanted device |
| Core Tip |
Gut-targeted therapies, such as probiotics and fecal microbiota transplantation, have shown potential for improving glycemic control and insulin sensitivity in type 2 diabetes mellitus patients. However, further research is needed to determine the optimal dose, duration, and safety of these therapies. Although many invention patents have been formed and put into clinical practice for the treatment of hypoglycemia targeting the intestine, the increasing results of basic research still mean greater room for progress. |
| Publish Date |
2024-01-02 09:08 |
| Citation |
Xu TC, Liu Y, Yu Z, Xu B. Gut-targeted therapies for type 2 diabetes mellitus: A review. World J Clin Cases 2024; 12(1): 1-8 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i1/1.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i1.1 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
